MAPT and Parkinson disease: PD-MCI patients showing cognitive worsening had significantly higher levels of CSF p-Tau, NfL, and sTREM2, when compared to cognitively stable PD-MCI patients (p = 0.0017, p = 0.042, and p = 0.047, respectively, Fig. 3).